Kinetics of postoperative serum vascular endothelial growth factor (VEGF) - Can it be used to predict curative resections in colorectal cancer?

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3717-3722

  Kumar, Harish ^a,b   Heer, Kamal ^a   Duthie, Graeme S ^a   Monson, John R T ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b Orchard House   (United Kingdom)

Author keywords

CT, computed tomography; IQR, inter quartile range; NPV, negative predictive value; PPV, positive predictive value; VEGF, vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER SURGERY; COLON RESECTION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL;

ADULT; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PALLIATIVE CARE; PREDICTIVE VALUE OF TESTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036875485     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gimborne MAJr, Leapman SB, Cotran RS and Folkman J: Tumour dormancy in vivo by prevention of neovascularisation. J Exp Med 136: 261-76, 1972.
2. Conn G, Soderman D, Schaffer MT, Wile M, Hatcher VB and Thomas KA: Purification of a glycoprotein vascular endothelial cell mitogen from glioma cell line. Proc Natl Acd Sci USA 87: 1323-1327, 1990.
3. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak H.F: Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC) 219: 983-985,1983.
4. Dvorak H: Tumours, wounds that do not heal. N Engl J Med 315: 1650-1659, 1986.
5. Shingo T, Yoshihiko Y, Shinichi K, Hideo S, Tooru M, Shizuo S and Tadao N: Concentration of vascular endothelial growth factor in the serum and tumour tissue of brain tumour patients. Cancer Res 56: 2185-2190, 1996.
6. Atsushi T, Hiroki S, Sun JK, Kenichi T, TadaoK, Taizi T, Yoshiaki K, Tadao K, Taiji T, Yoshiaki K, Takashi S and Masaaki T: Markedly increased amounts of mRNAs for vascular endothelial growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54: 4233-4237, 1994.
7. Claffy PK, Brown LF, del Aguila LF, Tognazzi K, Yeo K, Manceau EJ and Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumour growth, angiogenesis and experimental metastases. Cancer Res 56: 172-181, 1996.
8. Toi M, Kondo S, Suzuki H, Yamamoto Y, Inado K, Imazawa T, Tamiguchi T and Tominaga T: Quantitative analysis of vascular endothelial growth factor in primary breast carcinoma. Cancer 77: 1101-1106, 1996.
9. Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K, Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto N, Arai K, Yamada Y, Yoshihara H, Tujimura T, Kawano K,Yoshikawa K and Kamada T: Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56: 3004-3009, 1996.
10. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yshida M, Ikeda T and Tominaga T: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clinical Cancer Res 2: 821-826, 1996.
11. Chung YS, Meada K and Sowa M: Prognostic value of angiogenesis in gastro-intestinal tumours. Eur J Cancer 324: 2501-2505, 1996.
12. Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab, EA and Rubin DB: Tumour angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Annals of Surgery vol. 222, No 6: 695-699, 1995.
13. Saclarides TJ, Speziale NJ, Drab E, Szeluga DJ and Rubin DB: Tumour angiogenesis and rectal cancer. Dis Colon Rectum September: 921-926, 1994.
14. Heer K, Kumar H, Read JR, Fox JN, Monson JRT and Kerin MJ: Serum vascular endothelial growth factor in breast cancer-its relation with cancer type and oestrogen receptor status. Clin Cancer Res Nov 7(11): 3491-3494, 2001.
15. Ferrara N, Houck K, Jakeman L and Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrin Rev 13: 18-32, 1992.
16. Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW: The vascular endothelial growth factor family. Identification of a fourth molecular species and characterisation of alternative splicing of RNA. Mol Endocrin 5: 1806-1814, 1991.
17. Kumar H, Heer K, Lee PWR, Duthie GS, MacDonald AW, Greeman J, Kerin MJ and Monson JRT: Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 4(5): 1279-1285, 1998.
18. Chin K-F, Greenman J, Gardiner E, Kumar H, Topping K and Monson J: Preoperative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. British J Cancer 83(11): 1425-1431, 2000.
19. Salven P, Teerenhovi L and Joenuu H: A high pre-treatment serum vascular endothelial factor (VEGF) is associated with poor outcome in small cell lung cancer. Int J Cancer 79(2): 144-146, 1998.
20. Salven P, Ruotsalainen T, Mattson K and Joensuu H: A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 90(8): 3167-3172, 1997.